In addition to the important functions in the process of mitosis, TACC2, one of fusion partners, has been identified as a tumor suppressor gene in breast cancer [53] and hepatocellular carcinoma [54], the downregulation of which is an important step to drive tumorigenesis. The gene discussed is TACC2; the disease is breast carcinoma.